首页> 外国专利> PHARMACEUTICALLY AVAILABLE DERIVATIVES OF PROTOBERBERINE SALTS, PROTOBEREBERINE DERIVATIVES AND THEIR SALTS

PHARMACEUTICALLY AVAILABLE DERIVATIVES OF PROTOBERBERINE SALTS, PROTOBEREBERINE DERIVATIVES AND THEIR SALTS

机译:原小BER碱盐,原小E碱衍生物及其盐的药学上可用的衍生物

摘要

The antifungal formulation comprising the novel compounds of the following chemical formulae (I) and (II) exhibit in vitro antifungal activity against fungi including cutaneous filamentous fungus, such as Epidermophyton, Microsporum, Trichophyton, Sporothrix schenckii, Aspergillus or Candida. The formulation of the present invention exhibit in vitro antifungal activity at the concentration of 1-100 mu g/ml. wherein R1, R2, and R4 may be the same or different, and represent C1-C5 alkoxy, R3 represents hydrogen or C1-C10 alkyl, A- represents inorganic acid ion, organic acid ion or halide, R5 represents hydrogen, pyridylmethyl, substituted pyridylmethyl or a group having the following chemical formula(XI) wherein Z1, Z2, Z3, Z4 and Z5 may be the same or different and represent hydrogen, halogen, C1-C5 alkyl, trifluoromethyl, phenyl, substituted phenyl, nitro, C1-C4 alkoxy, C1-C4 alkylamino, acetylamino, C1-C8 trialkyl ammonium, guanidinyl, methylthio, ethylthio, trifluoromethoxy, hydroxy, phenoxy, vinyl, carboxyl and C1-C2 alkoxycarbonyl group.
机译:包含以下化学式(I)和(II)的新化合物的抗真菌制剂表现出对真菌的体外抗真菌活性,所述真菌包括皮肤丝状真菌,例如表皮真菌,微孢子菌,毛癣菌,申氏孢子菌,曲霉或念珠菌。本发明的制剂在1-100μg/ ml的浓度下表现出体外抗真菌活性。其中R1,R2和R4可以相同或不同,并且代表C1-C5烷氧基,R3代表氢或C1-C10烷基,A-代表无机酸离子,有机酸离子或卤化物,R5代表氢,吡啶基甲基,被取代吡啶甲基或具有以下化学式(XI)的基团,其中Z 1,Z 2,Z 3,Z 4和Z 5可以相同或不同,并且代表氢,卤素,C 1 -C 5烷基,三氟甲基,苯基,取代的苯基,硝基,C 1- C 4烷氧基,C 1 -C 4烷基氨基,乙酰氨基,C 1 -C 8三烷基铵,胍基,甲硫基,乙硫基,三氟甲氧基,羟基,苯氧基,乙烯基,羧基和C 1 -C 2烷氧基羰基。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号